Xu Wei, Zhang Yu, Hou Dianhai, Shen Jianjun, Dong Jinhua, Gao Zhiqin, Liu Honglin
Key Laboratory for Biological Medicine in Shandong Universities, Weifang Key Laboratory for Antibodies Medicine, School, of Life Science and Technology, Weifang Medical University, Weifang 261053, China.
College of Food Science and Engineering, Hefei University of Technology, Hefei 230009, China.
Anal Methods. 2023 Jun 22;15(24):2915-2924. doi: 10.1039/d3ay00583f.
Simultaneous and ultrasensitive detection of multiple microRNA (miRNA) biomarkers is an essential precondition for early cancer diagnosis and treatment. Here we developed a sandwich surface-enhanced Raman scattering (SERS) sensor based on Au@Ag core-shell nanorods combined with duplex specific nuclease-mediated signal amplification (DSNSA) for quantitative detection of multiple breast cancer miRNA biomarkers. The DSNSA strategy enables quantitative detection of target miRNA through rehybridizing the capture probe DNA-SERSnanotag conjugates to trigger signal amplification. The Au@Ag core-shell nanorods coated with an Ag shell exhibit excellent SERS performance, implying that molecules can be concentrated by the Ag shell at the hot spots. By monitoring the Raman signal attenuation of hot spots in the presence of target miRNAs, three breast cancer associated miRNAs (miR-21, miR-155, and let 7b) were simultaneously determined using the sandwich SERS sensor, and their detection limits (LODs) were 0.05 fM, 0.063 fM and 0.037 fM, respectively. These results indicated that our sandwich SERS sensor combined with the DSNSA strategy holds remarkable promise for multiplex detection of cancer biomarkers and contributes to early diagnosis of cancer.
同时超灵敏检测多种微小RNA(miRNA)生物标志物是癌症早期诊断和治疗的重要前提条件。在此,我们基于金@银核壳纳米棒并结合双链特异性核酸酶介导的信号放大(DSNSA)技术开发了一种夹心式表面增强拉曼散射(SERS)传感器,用于定量检测多种乳腺癌miRNA生物标志物。DSNSA策略通过使捕获探针DNA-SERS纳米标签共轭物重新杂交以触发信号放大,从而实现对目标miRNA的定量检测。涂有银壳的金@银核壳纳米棒表现出优异的SERS性能,这意味着分子可以被银壳在热点处富集。通过监测在存在目标miRNA时热点处的拉曼信号衰减,使用夹心SERS传感器同时测定了三种与乳腺癌相关的miRNA(miR-21、miR-155和let 7b),其检测限(LOD)分别为0.05 fM、0.063 fM和0.037 fM。这些结果表明,我们的夹心SERS传感器结合DSNSA策略在癌症生物标志物多重检测方面具有显著前景,并有助于癌症的早期诊断。